Report Detail

Medical Devices & Consumables Global Non-Invasive Neuromodulatory Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4688141
  • |
  • 27 April, 2026
  • |
  • Global
  • |
  • 111 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Non-Invasive Neuromodulatory Devices market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Non-Invasive Neuromodulation is neuromodulation that does not require a surgical procedure, such as TMS, TENS, ECT, or tES.
This report is a detailed and comprehensive analysis for global Non-Invasive Neuromodulatory Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Invasive Neuromodulatory Devices market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Invasive Neuromodulatory Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Invasive Neuromodulatory Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Invasive Neuromodulatory Devices market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Neuromodulatory Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Neuromodulatory Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Neuroelectrics, Aneuvo, Soterix Medical, Magstim, BrainsWay, ElectroCore Medical, NeuroCare Group, Koninklijke Philips, NESA World, DEYMED Diagnostic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-Invasive Neuromodulatory Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Transcutaneous Supraorbital Neurostimulation
Single-Pulse Transcranial Magnetic Stimulation
Non-invasive Vagal Nerve Stimulation
Others
Market segment by Application
Hospitals & Clinics
Cognitive Care Centers
Research Institutes
Others
Major players covered
Neuroelectrics
Aneuvo
Soterix Medical
Magstim
BrainsWay
ElectroCore Medical
NeuroCare Group
Koninklijke Philips
NESA World
DEYMED Diagnostic
electroCore
Medistar
Vagustim
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Invasive Neuromodulatory Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Invasive Neuromodulatory Devices, with price, sales quantity, revenue, and global market share of Non-Invasive Neuromodulatory Devices from 2021 to 2026.
Chapter 3, the Non-Invasive Neuromodulatory Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Invasive Neuromodulatory Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-Invasive Neuromodulatory Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Invasive Neuromodulatory Devices.
Chapter 14 and 15, to describe Non-Invasive Neuromodulatory Devices sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Non-Invasive Neuromodulatory Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Transcutaneous Supraorbital Neurostimulation
    • 1.3.3 Single-Pulse Transcranial Magnetic Stimulation
    • 1.3.4 Non-invasive Vagal Nerve Stimulation
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Non-Invasive Neuromodulatory Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals & Clinics
    • 1.4.3 Cognitive Care Centers
    • 1.4.4 Research Institutes
    • 1.4.5 Others
  • 1.5 Global Non-Invasive Neuromodulatory Devices Market Size & Forecast
    • 1.5.1 Global Non-Invasive Neuromodulatory Devices Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Non-Invasive Neuromodulatory Devices Sales Quantity (2021-2032)
    • 1.5.3 Global Non-Invasive Neuromodulatory Devices Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Neuroelectrics
    • 2.1.1 Neuroelectrics Details
    • 2.1.2 Neuroelectrics Major Business
    • 2.1.3 Neuroelectrics Non-Invasive Neuromodulatory Devices Product and Services
    • 2.1.4 Neuroelectrics Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Neuroelectrics Recent Developments/Updates
  • 2.2 Aneuvo
    • 2.2.1 Aneuvo Details
    • 2.2.2 Aneuvo Major Business
    • 2.2.3 Aneuvo Non-Invasive Neuromodulatory Devices Product and Services
    • 2.2.4 Aneuvo Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Aneuvo Recent Developments/Updates
  • 2.3 Soterix Medical
    • 2.3.1 Soterix Medical Details
    • 2.3.2 Soterix Medical Major Business
    • 2.3.3 Soterix Medical Non-Invasive Neuromodulatory Devices Product and Services
    • 2.3.4 Soterix Medical Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Soterix Medical Recent Developments/Updates
  • 2.4 Magstim
    • 2.4.1 Magstim Details
    • 2.4.2 Magstim Major Business
    • 2.4.3 Magstim Non-Invasive Neuromodulatory Devices Product and Services
    • 2.4.4 Magstim Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Magstim Recent Developments/Updates
  • 2.5 BrainsWay
    • 2.5.1 BrainsWay Details
    • 2.5.2 BrainsWay Major Business
    • 2.5.3 BrainsWay Non-Invasive Neuromodulatory Devices Product and Services
    • 2.5.4 BrainsWay Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BrainsWay Recent Developments/Updates
  • 2.6 ElectroCore Medical
    • 2.6.1 ElectroCore Medical Details
    • 2.6.2 ElectroCore Medical Major Business
    • 2.6.3 ElectroCore Medical Non-Invasive Neuromodulatory Devices Product and Services
    • 2.6.4 ElectroCore Medical Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 ElectroCore Medical Recent Developments/Updates
  • 2.7 NeuroCare Group
    • 2.7.1 NeuroCare Group Details
    • 2.7.2 NeuroCare Group Major Business
    • 2.7.3 NeuroCare Group Non-Invasive Neuromodulatory Devices Product and Services
    • 2.7.4 NeuroCare Group Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 NeuroCare Group Recent Developments/Updates
  • 2.8 Koninklijke Philips
    • 2.8.1 Koninklijke Philips Details
    • 2.8.2 Koninklijke Philips Major Business
    • 2.8.3 Koninklijke Philips Non-Invasive Neuromodulatory Devices Product and Services
    • 2.8.4 Koninklijke Philips Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Koninklijke Philips Recent Developments/Updates
  • 2.9 NESA World
    • 2.9.1 NESA World Details
    • 2.9.2 NESA World Major Business
    • 2.9.3 NESA World Non-Invasive Neuromodulatory Devices Product and Services
    • 2.9.4 NESA World Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 NESA World Recent Developments/Updates
  • 2.10 DEYMED Diagnostic
    • 2.10.1 DEYMED Diagnostic Details
    • 2.10.2 DEYMED Diagnostic Major Business
    • 2.10.3 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Product and Services
    • 2.10.4 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 DEYMED Diagnostic Recent Developments/Updates
  • 2.11 electroCore
    • 2.11.1 electroCore Details
    • 2.11.2 electroCore Major Business
    • 2.11.3 electroCore Non-Invasive Neuromodulatory Devices Product and Services
    • 2.11.4 electroCore Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 electroCore Recent Developments/Updates
  • 2.12 Medistar
    • 2.12.1 Medistar Details
    • 2.12.2 Medistar Major Business
    • 2.12.3 Medistar Non-Invasive Neuromodulatory Devices Product and Services
    • 2.12.4 Medistar Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Medistar Recent Developments/Updates
  • 2.13 Vagustim
    • 2.13.1 Vagustim Details
    • 2.13.2 Vagustim Major Business
    • 2.13.3 Vagustim Non-Invasive Neuromodulatory Devices Product and Services
    • 2.13.4 Vagustim Non-Invasive Neuromodulatory Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Vagustim Recent Developments/Updates

3 Competitive Environment: Non-Invasive Neuromodulatory Devices by Manufacturer

  • 3.1 Global Non-Invasive Neuromodulatory Devices Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Non-Invasive Neuromodulatory Devices Revenue by Manufacturer (2021-2026)
  • 3.3 Global Non-Invasive Neuromodulatory Devices Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Non-Invasive Neuromodulatory Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Non-Invasive Neuromodulatory Devices Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Non-Invasive Neuromodulatory Devices Manufacturer Market Share in 2025
  • 3.5 Non-Invasive Neuromodulatory Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Non-Invasive Neuromodulatory Devices Market: Region Footprint
    • 3.5.2 Non-Invasive Neuromodulatory Devices Market: Company Product Type Footprint
    • 3.5.3 Non-Invasive Neuromodulatory Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Non-Invasive Neuromodulatory Devices Market Size by Region
    • 4.1.1 Global Non-Invasive Neuromodulatory Devices Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Non-Invasive Neuromodulatory Devices Consumption Value by Region (2021-2032)
    • 4.1.3 Global Non-Invasive Neuromodulatory Devices Average Price by Region (2021-2032)
  • 4.2 North America Non-Invasive Neuromodulatory Devices Consumption Value (2021-2032)
  • 4.3 Europe Non-Invasive Neuromodulatory Devices Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Non-Invasive Neuromodulatory Devices Consumption Value (2021-2032)
  • 4.5 South America Non-Invasive Neuromodulatory Devices Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Non-Invasive Neuromodulatory Devices Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Non-Invasive Neuromodulatory Devices Sales Quantity by Type (2021-2032)
  • 5.2 Global Non-Invasive Neuromodulatory Devices Consumption Value by Type (2021-2032)
  • 5.3 Global Non-Invasive Neuromodulatory Devices Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Non-Invasive Neuromodulatory Devices Sales Quantity by Application (2021-2032)
  • 6.2 Global Non-Invasive Neuromodulatory Devices Consumption Value by Application (2021-2032)
  • 6.3 Global Non-Invasive Neuromodulatory Devices Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Non-Invasive Neuromodulatory Devices Sales Quantity by Type (2021-2032)
  • 7.2 North America Non-Invasive Neuromodulatory Devices Sales Quantity by Application (2021-2032)
  • 7.3 North America Non-Invasive Neuromodulatory Devices Market Size by Country
    • 7.3.1 North America Non-Invasive Neuromodulatory Devices Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Non-Invasive Neuromodulatory Devices Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Non-Invasive Neuromodulatory Devices Sales Quantity by Type (2021-2032)
  • 8.2 Europe Non-Invasive Neuromodulatory Devices Sales Quantity by Application (2021-2032)
  • 8.3 Europe Non-Invasive Neuromodulatory Devices Market Size by Country
    • 8.3.1 Europe Non-Invasive Neuromodulatory Devices Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Non-Invasive Neuromodulatory Devices Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Non-Invasive Neuromodulatory Devices Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Non-Invasive Neuromodulatory Devices Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Non-Invasive Neuromodulatory Devices Market Size by Region
    • 9.3.1 Asia-Pacific Non-Invasive Neuromodulatory Devices Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Non-Invasive Neuromodulatory Devices Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Non-Invasive Neuromodulatory Devices Sales Quantity by Type (2021-2032)
  • 10.2 South America Non-Invasive Neuromodulatory Devices Sales Quantity by Application (2021-2032)
  • 10.3 South America Non-Invasive Neuromodulatory Devices Market Size by Country
    • 10.3.1 South America Non-Invasive Neuromodulatory Devices Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Non-Invasive Neuromodulatory Devices Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Non-Invasive Neuromodulatory Devices Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Non-Invasive Neuromodulatory Devices Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Non-Invasive Neuromodulatory Devices Market Size by Country
    • 11.3.1 Middle East & Africa Non-Invasive Neuromodulatory Devices Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Non-Invasive Neuromodulatory Devices Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Non-Invasive Neuromodulatory Devices Market Drivers
  • 12.2 Non-Invasive Neuromodulatory Devices Market Restraints
  • 12.3 Non-Invasive Neuromodulatory Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Non-Invasive Neuromodulatory Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Non-Invasive Neuromodulatory Devices
  • 13.3 Non-Invasive Neuromodulatory Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Non-Invasive Neuromodulatory Devices Typical Distributors
  • 14.3 Non-Invasive Neuromodulatory Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Non-Invasive Neuromodulatory Devices. Industry analysis & Market Report on Non-Invasive Neuromodulatory Devices is a syndicated market report, published as Global Non-Invasive Neuromodulatory Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-Invasive Neuromodulatory Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report